Enzo scores $7M in patent battle with PerkinElmer

Enzo Biochem ($ENZ) picked up a $7 million settlement in its ongoing patent squabble with PerkinElmer ($PKI), resolving one of its many legal wrangles in life sciences. The suit was tied to alleged infringement of intellectual property related to diagnostics and sequencing, and Enzo has pursued similar claims against Roche Diagnostics ($RHHBY), LabCorp ($LH), Life Technologies and Affymetrix ($AFFY). News

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.